Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma
PHASE1CompletedINTERVENTIONAL
Enrollment
85
Participants
Timeline
Start Date
June 30, 1991
Study Completion Date
March 31, 2000
Conditions
Breast NeoplasmsLymphomaNeoplasm MetastasisTesticular Neoplasms
Interventions
DRUG
interleukin-1
Trial Locations (1)
20892
National Cancer Institute (NCI), Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00001270 - Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma | Biotech Hunter | Biotech Hunter